TILRAY BRANDS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.07 USD | -0.96% |
|
+6.15% | -10.00% |
| 05-14 | Stocks Uneven Pre-Bell as Wall Street Awaits Producer Price Report; Asia, Europe Churn | MT |
| 05-07 | Investors wary of US cannabis ETFs despite recent rally | RE |
| Sales 2024 * | 783M 61.75B | Sales 2025 * | 864M 68.18B | Capitalization | 1.67B 132B |
|---|---|---|---|---|---|
| Net income 2024 * | -226M -17.83B | Net income 2025 * | -85M -6.71B | EV / Sales 2024 * | 2.36 x |
| Net Debt 2024 * | 178M 14.04B | Net Debt 2025 * | 108M 8.56B | EV / Sales 2025 * | 2.06 x |
| P/E ratio 2024 * |
-6.3
x | P/E ratio 2025 * |
-14.6
x | Employees | 1,600 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.73% |
More Fundamentals
* Assessed data
More news
Latest transcript on Tilray Brands, Inc.
More recommendations
More press releases
More news
| 1 day | -1.21% | ||
| 1 week | +6.15% | ||
| Current month | -16.19% | ||
| 1 month | +16.29% | ||
| 3 months | +11.89% | ||
| 6 months | +13.74% | ||
| Current year | -10.00% |
1 week
1.92
2.31
1 month
1.652.52
Current year
1.602.97
1 year
1.503.40
3 years
1.5023.04
5 years
1.5023.04
10 years
1.5023.04
| Managers | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 65 | 29/04/21 |
Carl Merton
DFI | Director of Finance/CFO | - | 29/04/21 |
Lloyd Brathwaite
CTO | Chief Tech/Sci/R&D Officer | - | 29/04/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 65 | 29/04/21 |
David Clanachan
BRD | Director/Board Member | 62 | 29/04/21 |
Walter Robb
BRD | Director/Board Member | 70 | 29/04/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.94% | 39 M€ | +32.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/24 | 2.07 | -0.96% | 18,884,244 |
| 14/05/24 | 2.09 | +5.03% | 59,363,373 |
| 13/05/24 | 1.99 | +3.11% | 19,828,424 |
| 10/05/24 | 1.93 | -2.53% | 14,859,514 |
| 09/05/24 | 1.98 | +1.54% | 20,737,875 |
Delayed Quote Nasdaq, May 15, 2024 at 09:00 pm
More quotes
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.
Sector
Pharmaceuticals
Calendar
23/07/2024
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
2.07
USD
Average target price
2.375
USD
Spread / Average Target
+14.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.00% | 1.67B | |
| +35.01% | 709B | |
| +30.96% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.42% | 239B | |
| +9.41% | 211B | |
| -4.29% | 203B | |
| +10.77% | 171B |
- Stock Market
- Equities
- TLRY Stock
